http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7a06f64138ebd5503d98cb19408effe
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Haber |
| name | Daniel A. Haber Daniel A Haber |
| given-name | Daniel A. Daniel A |
| organization-name | Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Building 149, 13th Street, Charlestown, MA 02129, USA. Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129; Division of Pediatric Oncology, Dana–Farber Cancer Institute, Boston, MA 02115; Department of Pathology, Memorial Sloan–Kettering Cancer Center, New York, NY 10021; Axys Pharmaceuticals, San Diego, CA 92037; University of Texas, Southwestern Medical Center, Dallas, TX 75235; St. Jude Children’s Research Hospital, Memphis, TN 38101; and Center for Cancer Research, Massachusetts Institute of Technology,... Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;; Howard Hughes Medical Institute, Bethesda, MD 20815; 6Pathology, Massachusetts General Hospital;; 7Massachusetts General Hospital Cancer Center; Departments of 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; 2Division of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; 7Howard Hughes Medical Institute, Chevy Chase, Maryland. 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts and 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.; 2Howard Hughes Medical Institute, Chevy Chase, Maryland. *Massachusetts General Hospital Cancer Center,; Howard Hughes Medical Institute and; Harvard Medical School, Charlestown, MA 02129; and Massachusetts General Hospital Cancer Center; Harvard Medical School, Boston, MA Massachusetts General Hospital Cancer Center; Harvard Medical School; Charlestown; USA; Department of Medicine 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 3Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; 9Howard Hughes Medical Institute, Chevy Chase, Maryland. Massachusetts General Hospital Cancer Center,Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129;; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;; Howard Hughes Medical Institute, Chevy Chase, MD 20815 Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 3Dana-Farber Cancer Center, Boston, Massachusetts.; 2Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital Cancer Center, Harvard Medical School, 149 13th Street, Room 7-101, Charlestown, MA 20129 1Massachusetts General Hospital Cancer Center; Departments of; 2Medicine and Massachusetts General Hospital Cancer Center Harvard Medical School Boston 55 Fruit Street Boston MA 02114 USA; Howard Hughes Medical Institute 4000 Jones Bridge Road Chevy Chase MD 20815 USA 1Division of Hematology/Oncology, Massachusetts General Hospital; 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.; 2Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.; 5Howard Hughes Medical Institute, Chevy Chase, Maryland. Massachusetts General Hospital Cancer Center and Authors' Affiliation: Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts Massachusetts General Hospital Cancer Center, Harvard Medical School/Partners HealthCare Center for Genetics and Genomics, Massachusetts General Hospital Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts,USA 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 6Howard Hughes Medical Institute, Chevy Chase, Maryland. Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.; Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA. Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Authors' Affiliations: 1Genentech, San Francisco, California; 2Massachusetts General Hospital, Boston, Massachusetts; 3Howard Hughes Medical Institute, Chevy Chase, Maryland; 4Melanoma Research Alliance, Washington, DC; 5Friends of Cancer Research, Washington, DC; 6Investigational Drug Branch, CTEP, National Cancer Institute, Rockville, Maryland; and 7Memorial Sloan-Kettering Cancer Center, New York, New York; Authors' Affiliations: 1Genentech, San Francisco, California; 2Massachusetts General Hospital, Boston, Massachusetts; 3Howard Hughes Medical Institute, Chevy Chase, Maryland; 4Melanoma Research Alliance, Washington, DC; 5Friends of Cancer Research, Washington, DC; 6Investigational Drug Branch, CTEP, National Cancer Institute, Rockville, Maryland; and 7Memorial Sloan-Kettering Cancer Center, New York, New York Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; and Howard Hughes Medical Institute, Chevy Chase, MD Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.; Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts Howard Hughes Medical Institute, Bethesda, MD, USA. Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 3Massachusetts General Hospital Center for Cancer Research, Harvard Medical School, Boston, Massachusetts.; 4Howard Hughes Medical Institute, Chevy Chase, Maryland. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02129, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;; Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;; Howard Hughes Medical Institute, Chevy Chase, MD 20815 Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.; Howard Hughes Medical Institute. Massachusetts General Hospital Cancer Center, Boston, MA 1Cancer Center and Departments of; 2Medicine and Authors' Affiliation: Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts From the Massachusetts General Hospital Cancer Center and Department of Pathology, Harvard Medical School, Charlestown, MA; Vanderbilt-Ingram Cancer Center, Nashville, TN; Free University Hospital, Amsterdam, the Netherlands; The University of Texas M.D. Anderson Cancer Center, Houston, TX; Heidelberg University Medical Centre, Mannheim, Germany; Kinki University School of Medicine, Osaka, Japan; Memorial Sloan-Kettering Cancer Center, New York, NY; Vall d'Hebron University Hospital, Barcelona, Spain;... 1Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts and Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; Howard Hughes Medical Institute, Chevy Chase, MD 1Massachusetts General Hospital Cancer Center, Harvard Medical School; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114;; Department of Medicine, Harvard Medical School, Boston, MA 02114;; Howard Hughes Medical Institute, Chevy Chase, MD 20815 Howard Hughes Medical Institute 1 , 2 , and 3; Massachusetts General Hospital Cancer Center 1 , 2 , and 3; Center for Engineering in Medicine, Harvard Medical School, Charlestown, MA 02129 1 , 2 , and 3; Howard Hughes Medical Institute 1 , 2 , and 3; Massachusetts General Hospital Cancer Center 1 , 2 , and 3; Center for Engineering in Medicine, Harvard Medical School, Charlestown, MA 02129 1 , 2 , and 3 Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, United States Massachusetts General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. 4Cancer Center and Authors' Affiliations: 1Massachusetts General Hospital Cancer Center and 2Center for Molecular Therapeutics, Harvard Medical School, Charlestown, Massachusetts; 3Howard Hughes Medical Institute, 4Center for Head and Neck Cancers, 5Department of Pathology, and 6Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; 7Biotheranostics, San Diego, California; and Departments of 8Pathology and 9Medicine, University of Chicago, Chicago, Illinois; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center and 2Center for Molecular Therapeutics, Harvard Medical School, Charlestown, Massachusetts; 3Howard Hughes Medical Institute, 4Center for Head and Neck Cancers, 5Department of Pathology, and 6Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; 7Biotheranostics, San Diego, California; and Departments of 8Pathology and 9Medicine, University of Chicago, Chicago, Illinois Massachusetts General Hospital Cancer Center and Harvard Medical School, Building 149, 13th Street, Charlestown, MA 02129 From the Massachusetts General Hospital Cancer Center; Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital; Department of Pathology, Massachusetts General Hospital; Department of Biostatistics, Massachusetts General Hospital, Boston; Harvard Medical School/Partners Health Care Center for Genetics and Genomics, Cambridge, MA; University of Washington, Seattle, WA; Sarah Cannon Research Institute, Nashville, TN; Fletcher Allen Health Care, Burlington, VT; Fairfax-Northern... Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Howard Hughes Medical Institute, Chevy Chase, MD 20815 Cancer Center, Massachusetts General Hospital Boston MA; Harvard Medical School Boston MA Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.; Howard Hughes Medical Institute, Massachusetts General Hospital, Charlestown, MA 02129, USA. Cancer Center, Massachusetts General Hospital; Boston; USA; Harvard Medical School; Boston 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts; and Authors' Affiliations: 1Massachusetts General Hospital Cancer Center; 2Dana-Farber Cancer Institute, Boston, Massachusetts; and 3Center for Computer Vision and Imaging Biomarkers, University of California, Los Angeles, California Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129 Authors' Affiliations: 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts and 2Howard Hughes Medical Institute; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts and 2Howard Hughes Medical Institute Cancer Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129; and Center for Molecular Therapeutics and Medical Oncology Unit, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129; and Departments of Oncology Research and Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965 Howard Hughes Medical Institute, Chevy Chase, MD, USA. 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 5Harvard Medical School, Boston, Massachusetts.; 8Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; 15Howard Hughes Medical Institute, Chevy Chase, Maryland. Massachusetts General Hospital Cancer Center, Boston, MA; 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA, USA.; Department of Medicine and Massachusetts General Hospital Cancer Center, Harvard Medical, School, Boston, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA. 1Cancer Center and Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.; 3Howard Hughes Medical Institute, Chevy Chase, Maryland. Massachusetts General Hospital Cancer Center, Harvard Medical Center, Boston, MA 02114, USA.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Division of Molecular Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA. Cancer Center, Massachusetts General Hospital, Boston, MA 02114;; Harvard Medical School, Boston, MA 02115;; Howard Hughes Medical Institute, Bethesda, MD 20815 Authors' Affiliations: 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; 2Howard Hughes Medical Institute, Chevy Chase; and 3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; 2Howard Hughes Medical Institute, Chevy Chase; and 3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;; Howard Hughes Medical Institute, Chevy Chase, MD 20815;; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114; From the Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA *Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13th Street, Charlestown, MA 02129; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129; Authors' Affiliation: Massachusetts General Hospital Cancer Center, Boston, Massachusetts 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts; From the Department of Pediatrics, IRCCS Policlinico S. Matteo, Pavia, Italy; Children's Research Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan; Biologia Generale e Genetica Medica, Università di Pavia, Pavia, Italy; Massachusetts General Hospital Cancer Center, Boston, MA; and Children's Hospital of Philadelphia, Philadelphia, PA. Laboratory of Molecular Genetics, Massachusetts General Hospital Cancer Center, Boston, MA 02129. 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; 3Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; 8Howard Hughes Medical Institute, Bethesda, Maryland. 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; 2Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; 3Howard Hughes Medical Institute, Chevy Chase, Maryland. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. 1Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts and Massachusetts General Hospital Cancer Center and Departments of Medicine, Pathology, and Surgery, Harvard Medical School, Boston, MA 02114, USA. Massachusetts General Hospital Center for Cancer Risk Analysis and Harvard Medical School, Building 149, Charlestown, MA 02129, USA. Massachusetts General Hospital Cancer Center, 149 13th Street, 02129, Charlestown, Massachusetts, USA Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02467, USA.; Howard Hughes Medical Institute, Bethesda, MD 20815, USA. Authors' Affiliations: 1Massachusetts General Hospital Cancer Center, 2Center for Bioengineering in Medicine and Departments of 3Radiation Oncology, 4Medicine, 5Surgery and 6Pathology, Harvard Medical School, Charlestown, Massachusetts; 7Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York; and 8Howard Hughes Medical Institute, Chevy Chase, Maryland; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center, 2Center for Bioengineering in Medicine and Departments of 3Radiation Oncology, 4Medicine, 5Surgery and 6Pathology, Harvard Medical School, Charlestown, Massachusetts; 7Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York; and 8Howard Hughes Medical Institute, Chevy Chase, Maryland; Authors' Affiliations: 1Massachusetts General Hospital Cancer Center, 2Center for Bioengineering in Medicine and Departments of 3Radiation Oncology, 4Medicine, 5Surgery and 6Pathology, Harvard Medical School, Charlestown, Massachusetts; 7Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York; and 8Howard Hughes Medical Institute, Chevy Chase, Maryland Cancer Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, United States; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, United States; Howard Hughes Medical Institute, Massachusetts General Hospital, Harvard Medical School, Charlestown, United States Massachusetts General Hospital Cancer Center Harvard Medical School Charlestown MA USA; Department of Medicine Harvard Medical School Charlestown MA USA; Howard Hughes Medical Institute Chevy Chase MD USA Massachusetts General Hospital Cancer Center; Harvard Medical School; Boston; USA; Department of Medicine Massachusetts General Hospital Cancer Center, Boston, MA 02129, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129-2020 Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA 1Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts; Jochen K. Lennerz, A. John Iafrate, Kristin Bergethon, Gregory Y. Lauwers, Daniel A. Haber, Eunice L. Kwak, Jeffrey W. Clark, Allison Ackerman, Massachusetts General Hospital/Harvard Medical School, Boston, MA; Michael Michael, Stephen B. Fox, Benjamin J. Solomon, Peter MacCallum Cancer Centre, Melbourne, Australia; James G. Christensen, Keith D. Wilner, Pfizer, La Jolla, CA; Ravi Salgia, University of Chicago, Chicago, IL; and Yung-Jue Bang, Seoul National University Hospital, Seoul, South Korea. *Cancer Center and 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts; 2Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts; 3Department of Molecular Biology, Massachusetts General Hospital, Department of Genetics, Harvard Medical School, and Broad Institute for Biomedical Research, Boston, Massachusetts; and 4Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129; and Department of Anthropology, Harvard University, Cambridge, MA 02138 Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139; Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 9Howard Hughes Medical Institute, Chevy Chase, Maryland. 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts.; 12Howard Hughes Medical Institute, Chevy Chase, Maryland. From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114;; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; and; Howard Hughes Medical Institute, Chevy Chase, MD 20815 Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114;; Howard Hughes Medical Institute, Chevy Chase, MD 20815 |
Incoming Links
Total number of triples: 374.